In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.
Advertisement
Set Alert for Articles By Tom Gallen

Latest From Tom Gallen

Cooper-Vemedia Strengthens In Europe With Diepharmex Acquisition

Switzerland's Laboratoires Diepharmex has been snapped up by Cooper-Vemedia, the pan-European consumer healthcare group backed by private-equity firm Charterhouse Capital Partners.
Deals Europe

Reckitt Names New CEO To Ignite Growth And Lead Digital Transformation

Reckitt Benckiser has poached PepsiCo's global chief commercial officer, Laxman Narasimhan, to replace Rakesh Kapoor as the UK-based firm's CEO. Setting his stall out early, Narasimhan has made clear that RB's "capabilities and culture" need to change to make the company fit for the new digital world.
Appointments Business Strategies

Italian Hepatitis Cases Linked to Turmeric Supplements Hit 20, French & German Products Implicated

As cases of hepatitis linked to the consumption of turmeric supplements mount up - with products manufactured in France and Germany now implicated - the Italian authorities are coming under increasing pressure to identify the cause of the outbreak.
Europe Italy

Stada Reveals Skin-Care Ambitions With Acquisition Of GSK Brands

Stada has snapped up a basket of OTC skin-care brands from GSK, with CEO Peter Goldschmidt telling HBW Insight that the category is a "key focus" for the Germany-based firm.
Deals Business Strategies

Medical Marijuana Inc. Claims First CBD Supplement Approval In EU

Bulgaria has granted US-based Medical Marijuana Inc. the right to sell CBD as a supplement in a first for an EU country. The move, which will see CBD regulated as a traditional food, puts Bulgaria directly at odds with the European Commission, which recently classified the cannabis plant extract as a novel food.
Dietary Supplements Bulgaria

Comparison Claims Must Be Verifiable, UK Ad Regulator Warns Reckitt

Failure to give consumers opportunity to verify claims made in an ad for its Lemsip cold and flu brand has landed Reckitt Benckiser in hot water with the UK Advertising Standards Authority. 
Europe Health
See All
Advertisement
UsernamePublicRestriction

Register